About Amarantus bioscience

About company

Amarantus BioSciences is a development-stage, publicly-traded biotechnology company discovering and developing first-in-class treatments for diseases associated with the dysfunction of a wide range of biological pathways, beginning with apoptosis. The company focuses on developing therapeutic products for orphan drug designation in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine, and diagnostics in neurology. its prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia.